AU2023900376A0 - Biomarkers and uses thereof - Google Patents

Biomarkers and uses thereof

Info

Publication number
AU2023900376A0
AU2023900376A0 AU2023900376A AU2023900376A AU2023900376A0 AU 2023900376 A0 AU2023900376 A0 AU 2023900376A0 AU 2023900376 A AU2023900376 A AU 2023900376A AU 2023900376 A AU2023900376 A AU 2023900376A AU 2023900376 A0 AU2023900376 A0 AU 2023900376A0
Authority
AU
Australia
Prior art keywords
biomarkers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023900376A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Percheron Therapeutics Ltd
Original Assignee
Antisense Therapeutics Ltd
Filing date
Publication date
Application filed by Antisense Therapeutics Ltd filed Critical Antisense Therapeutics Ltd
Publication of AU2023900376A0 publication Critical patent/AU2023900376A0/en
Priority to PCT/AU2023/050777 priority Critical patent/WO2024036373A1/en
Pending legal-status Critical Current

Links

AU2023900376A 2022-08-16 2023-02-16 Biomarkers and uses thereof Pending AU2023900376A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2023/050777 WO2024036373A1 (en) 2022-08-16 2023-08-16 Biomarkers and uses thereof in diagnosis and treatment of neurological post acute sequelae of covid 19 (npasc)

Publications (1)

Publication Number Publication Date
AU2023900376A0 true AU2023900376A0 (en) 2023-03-02

Family

ID=

Similar Documents

Publication Publication Date Title
EP4141538A4 (en) Softbox and chuck assembly therefor
EP4039708A4 (en) Anti-cll1 antibody and application thereof
AU2022298850A1 (en) Anti-ccr8 antibodies and uses thereof
AU2023900376A0 (en) Biomarkers and uses thereof
AU2023902061A0 (en) Biomarkers and uses therefor
AU2022901154A0 (en) Biomarkers and uses therefor
AU2022900109A0 (en) Biomarkers and uses therefor
GB202306925D0 (en) Biomarkers and uses thereof
AU2023901461A0 (en) AIPROPERTY and AIREALESTATE
AU2022900253A0 (en) Prognostic biomarkers and uses therefor
AU2023902113A0 (en) Compounds and uses therefor
AU2023902115A0 (en) Compounds and Uses Therefor
AU2023901760A0 (en) Compounds and uses therefor
AU2023901070A0 (en) Aptamers and uses therefor
AU2023901071A0 (en) Aptamers and uses therefor
AU2023901069A0 (en) Aptamers and uses therefor
AU2022900861A0 (en) Aptamers and uses therefor
AU2022900858A0 (en) Aptamers and uses therefor
AU2022900859A0 (en) Aptamers and uses therefor
TWI842575B (en) Positioning structure and positioning decive
IL304313A (en) Novel biomarkers and uses thereof
AU2023901399A0 (en) Anti-SARS-CoV-2 antibodies and uses thereof
AU2023901335A0 (en) Anti-NPY-Y1 antibodies and uses thereof
AU2022901304A0 (en) Polypeptides and uses therefor
AU2022901165A0 (en) Anti-NPY-Y1 antibodies and uses thereof